Your browser doesn't support javascript.
COVID-19 vaccines and multiple sclerosis disease-modifying therapies.
Giovannoni, Gavin; Hawkes, Christopher H; Lechner-Scott, Jeannette; Levy, Michael; Yeh, E Ann; Baker, David.
  • Giovannoni G; Blizard Institute, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, UK. Electronic address: g.giovannoni@qmul.ac.uk.
  • Hawkes CH; Blizard Institute, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, UK.
  • Lechner-Scott J; Blizard Institute, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, UK.
  • Levy M; Blizard Institute, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, UK.
  • Yeh EA; Blizard Institute, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, UK.
  • Baker D; Blizard Institute, Barts and The London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, UK.
Mult Scler Relat Disord ; 53: 103155, 2021 08.
Article in English | MEDLINE | ID: covidwho-1313348
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Multiple Sclerosis Topics: Vaccines Limits: Humans Language: English Journal: Mult Scler Relat Disord Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Multiple Sclerosis Topics: Vaccines Limits: Humans Language: English Journal: Mult Scler Relat Disord Year: 2021 Document Type: Article